Arkolith/Insider Trading/CLSD/Form 4

Lasezkay George M

CEO, DirectorClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Jan 20, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$29K
Net Open-Market Flow
-$29K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 19, 2023Sell(S)20K$1.46$29K485K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-004274) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML